2.Unclassified B-cell lymphomas with "grey zone" characteristics.
Chinese Journal of Pathology 2011;40(4):278-281
Diagnosis, Differential
;
Gene Rearrangement
;
Hodgkin Disease
;
genetics
;
metabolism
;
pathology
;
Humans
;
Lymphoma, B-Cell
;
genetics
;
metabolism
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
genetics
;
metabolism
;
pathology
;
Mediastinal Neoplasms
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
genetics
;
metabolism
3.Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case.
Chinese Journal of Pathology 2010;39(1):54-55
Adenocarcinoma, Mucinous
;
pathology
;
Adult
;
Breast Neoplasms
;
metabolism
;
pathology
;
surgery
;
Carcinoma
;
pathology
;
Carcinoma in Situ
;
metabolism
;
pathology
;
surgery
;
Carcinoma, Ductal, Breast
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Female
;
Fibrocystic Breast Disease
;
metabolism
;
pathology
;
surgery
;
Humans
;
Hyperplasia
;
Lactalbumin
;
metabolism
;
S100 Proteins
;
metabolism
4.Classic Hodgkin's lymphoma in post-treatment hairy cell leukemia: report of a case.
Chinese Journal of Pathology 2011;40(12):848-849
Aged
;
Antibodies, Monoclonal, Murine-Derived
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bleomycin
;
therapeutic use
;
Dacarbazine
;
therapeutic use
;
Doxorubicin
;
therapeutic use
;
Hodgkin Disease
;
drug therapy
;
pathology
;
Humans
;
Leukemia, Hairy Cell
;
drug therapy
;
pathology
;
surgery
;
Male
;
Mitoxantrone
;
administration & dosage
;
Neoplasms, Multiple Primary
;
drug therapy
;
pathology
;
surgery
;
Rituximab
;
Splenectomy
;
Vidarabine
;
administration & dosage
;
analogs & derivatives
;
Vinblastine
;
therapeutic use
5.Diffuse large B-cell lymphoma of prostate: report of a case.
Gong-wei WANG ; Ding-bao CHEN ; Dan-hua SHEN
Chinese Journal of Pathology 2011;40(6):412-413
Aged, 80 and over
;
Antigens, CD20
;
metabolism
;
CD79 Antigens
;
metabolism
;
Diagnosis, Differential
;
Humans
;
Interferon Regulatory Factors
;
metabolism
;
Ki-67 Antigen
;
metabolism
;
Leukosialin
;
metabolism
;
Lymphoma, Large B-Cell, Diffuse
;
metabolism
;
pathology
;
surgery
;
Male
;
Neoplasms, Muscle Tissue
;
metabolism
;
pathology
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
surgery
;
Prostatitis
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Receptor Protein-Tyrosine Kinases
;
metabolism
6.B/T-cell biphenotypic lymphoblastic lymphoma/leukemia: report of a case.
Ding-bao CHEN ; Ying WANG ; Lin DAI
Chinese Journal of Pathology 2013;42(10):704-705
Adult
;
Biopsy
;
CD3 Complex
;
metabolism
;
DNA Nucleotidylexotransferase
;
metabolism
;
Female
;
Humans
;
Leukemia, Biphenotypic, Acute
;
metabolism
;
pathology
;
Lymph Nodes
;
metabolism
;
pathology
;
Neck
;
PAX5 Transcription Factor
;
metabolism
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
metabolism
;
pathology
7.Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case.
Ding-bao CHEN ; Ying WANG ; Dan-hua SHEN
Chinese Journal of Pathology 2010;39(9):635-636
Aged
;
Antibodies, Monoclonal, Murine-Derived
;
therapeutic use
;
Antigens, CD20
;
metabolism
;
Antineoplastic Agents
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bleomycin
;
therapeutic use
;
CD79 Antigens
;
metabolism
;
Cyclophosphamide
;
therapeutic use
;
Dacarbazine
;
therapeutic use
;
Doxorubicin
;
therapeutic use
;
Female
;
Hodgkin Disease
;
drug therapy
;
metabolism
;
pathology
;
surgery
;
Humans
;
Lymphoma, Large B-Cell, Diffuse
;
metabolism
;
pathology
;
surgery
;
therapy
;
Neoplasms, Second Primary
;
metabolism
;
pathology
;
surgery
;
therapy
;
Prednisone
;
therapeutic use
;
Rituximab
;
Vinblastine
;
therapeutic use
;
Vincristine
;
therapeutic use
8.In situ lymphoma.
Ding-bao CHEN ; Lin DAI ; Song-lin LIAO
Chinese Journal of Pathology 2009;38(11):790-792
CD5 Antigens
;
metabolism
;
Chromosomes, Human, Pair 11
;
Chromosomes, Human, Pair 14
;
Chromosomes, Human, Pair 18
;
Cyclin D1
;
metabolism
;
Diagnosis, Differential
;
Humans
;
Ki-67 Antigen
;
metabolism
;
Lymphoma, B-Cell, Marginal Zone
;
genetics
;
metabolism
;
pathology
;
Lymphoma, Follicular
;
genetics
;
metabolism
;
pathology
;
radiotherapy
;
Lymphoma, Mantle-Cell
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Pseudolymphoma
;
metabolism
;
pathology
;
Translocation, Genetic
9.Fever burden independently contributes to increased poor outcome of patients with traumatic brain injury
Long BAO ; Feng XU ; Li DING ; Weihua LING ; Du CHEN
Chinese Journal of Emergency Medicine 2014;23(5):491-495
Objective To investigate the prognostic value of fever burden in traumatic brain injury (TBI) patients.Methods A retrospective analysis of 355 TBI patients admitted to the emergency department and intensive care unit from November 2010 to October 2012 was performed,and the Glasgow outcome scale (GOS) was followed-up 6 months after the injury.The patients were divided into two groups according to the GOS:good outcome group (4 to 5) and poor outcome group (1 to 3).Relevant clinical findings were studied by statistical description,logistic regression analysis,Spearman correlation analysis and ROC curve analysis.Results Fever burden level was continuously increased with the decrease of GOS from score 5 to 2,except for score 1 of GOS,which was corresponding to a significant lower fever burden.There were significant differences in age,pupil reactivity,Glasgow coma scale (GCS) and fever burden between two groups (P < 0.05).Compared to the good outcome group,the poor outcome group was featured with more advanced average age (P =0.000),poorer pupil reactivity (P =0.000),lower GCS score (P =0.000) and higher fever burden level (P =0.000).Univariate logistic regression analysis suggested that age,GCS,pupil reactivity and fever burden level (OR 1.166,95% CI:1.117-1.217) were associatedwith poor outcome.The fever burden level and the other independent prognostic predictors as age,GCS and pupil reactivity were further included in the multivariate logistic regression model,and the adjusted OR of fever burden level was 1.098 (95% CI:1.031-1.169,P =0.003).ROC curve analysis showed the respective AUC for fever burden was 0.713 (95% CI:0.663-0.760).The relevant analysis revealed a significant negative correlation between the fever burden and the GOS score (r =-0.376,95% CI:-0.462--0.283,P =0.000).Conclusions Fever burden can be considered as an independent predictor of poor outcome of patients with TBI.The TBI patients with early onset of high levels of fever burden will have increased poor outcome risk.